Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review

Janna de Boer*, Erik Boot, Lissa van Gils, Therese van Amelsvoort, Janneke Zinkstok

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)2292-2306
Number of pages15
JournalAmerican Journal of Medical Genetics Part A
Volume179
Issue number11
Early online date13 Aug 2019
DOIs
Publication statusPublished - Nov 2019

Keywords

  • 22q11
  • 2 deletion syndrome
  • adverse effects
  • antipsychotic medication
  • systematic review
  • CARDIO-FACIAL SYNDROME
  • TREATMENT-RESISTANT PSYCHOSIS
  • ONSET PARKINSON DISEASE
  • RISK-FACTORS
  • SCHIZOPHRENIA
  • CLOZAPINE
  • ADULTS
  • NEUTROPENIA
  • ADOLESCENT
  • CHILDHOOD

Cite this